EAT is up +49.38%% since April’24 pick View All Top Buy Picks
Currently predicting for Mon, 1 Jul 2024

Trading levels for POLB.L

Fibonacci Support & Resistance Levels

Level Price
R3 13.65 5.35%
R2 13.42 3.58%
R1 13.28 2.49%
Price 12.96
S1 12.82 -1.05%
S2 12.68 -2.14%
S3 12.45 -3.91%

Accumulated Volume Support & Resistance Levels

Level Price
R3 14.90 14.97%
R2 13.35 3.01%
R1 13.20 1.85%
Price 12.96
S1 12.80 -1.23%
S2 12.75 -1.62%
S3 12.05 -7.02%

POLB.L Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About Poolbeg Pharma PLC

Poolbeg Pharma PLC Poolbeg Pharma plc operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an in­licensed first­in­class intranasally administered RNA­based immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro­ and nano... POLB.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT